ROCKWELL MEDICAL, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
ROCKWELL MEDICAL, INC. (RMTI) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $2.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $2.45M.
- ROCKWELL MEDICAL, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $1.01M, a 50.00% decline from fiscal 2024.
- ROCKWELL MEDICAL, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $2.01M.
- ROCKWELL MEDICAL, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- ROCKWELL MEDICAL, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $768.00K, a 81.79% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.45M 10-Q · filed 2026-08-13 | $2.45M derived: sum of 3 quarters · filed 2026-08-13 | $2.45M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $2.45M 10-Q · filed 2026-05-07 | $2.45M derived: sum of 2 quarters · filed 2026-05-07 | $2.45M derived: sum of 3 quarters · filed 2026-05-07 | $3.46M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $1.01M derived: sum of 3 quarters · filed 2026-08-13 | $1.01M 10-K · filed 2026-03-26 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.01M derived: sum of 2 quarters · filed 2026-08-13 | $1.01M 10-Q · filed 2025-11-12 | $1.03M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.01M 10-Q · filed 2026-08-13 | $1.03M derived: sum of 3 quarters · filed 2026-08-13 | $1.47M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | $28.00K derived: sum of 2 quarters · filed 2026-05-07 | $463.00K derived: sum of 3 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $463.00K derived: sum of 2 quarters · filed 2026-03-26 | $2.01M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | $435.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.98M 10-Q · filed 2025-11-12 | |||||
| 2024-06-30 | $1.55M 10-Q · filed 2025-08-14 | ||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | $0.00 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |||||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | ||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $768.00K derived: sum of 2 quarters · filed 2024-03-21 | $768.00K derived: sum of 3 quarters · filed 2024-03-21 | $768.00K 10-K · filed 2024-03-21 | |||
| 2022-09-30 | $768.00K 10-Q · filed 2022-11-14 | $768.00K derived: sum of 2 quarters · filed 2022-11-14 | $768.00K 10-Q · filed 2022-11-14 | $896.00K derived: sum of 4 quarters · filed 2023-03-30 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | $128.00K derived: sum of 3 quarters · filed 2023-03-30 | $846.00K derived: sum of 4 quarters · filed 2023-03-30 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | $128.00K derived: sum of 2 quarters · filed 2023-03-30 | $846.00K derived: sum of 3 quarters · filed 2023-03-30 | $2.32M derived: sum of 4 quarters · filed 2023-03-30 | |||
| 2021-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $846.00K derived: sum of 2 quarters · filed 2023-03-30 | $2.32M derived: sum of 3 quarters · filed 2023-03-30 | $4.22M 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $718.00K 10-Q · filed 2022-11-14 | $2.19M derived: sum of 2 quarters · filed 2022-11-14 | $4.09M 10-Q · filed 2022-11-14 | $4.36M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $1.48M 10-Q · filed 2022-08-15 | $3.37M 10-Q · filed 2022-08-15 | $3.64M derived: sum of 3 quarters · filed 2022-08-15 | $3.64M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $1.90M 10-Q · filed 2022-05-16 | $2.16M derived: sum of 2 quarters · filed 2022-05-16 | $2.16M derived: sum of 3 quarters · filed 2022-05-16 | $2.16M derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $268.00K derived: sum of 2 quarters · filed 2022-04-08 | $268.00K derived: sum of 3 quarters · filed 2022-04-08 | $268.00K 10-K · filed 2022-04-08 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | $635.00K derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | $635.00K derived: sum of 3 quarters · filed 2021-08-16 | $771.00K derived: sum of 4 quarters · filed 2021-08-16 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 | $635.00K derived: sum of 2 quarters · filed 2021-05-17 | $771.00K derived: sum of 3 quarters · filed 2021-05-17 | $1.59M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $635.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $771.00K derived: sum of 2 quarters · filed 2021-03-31 | $1.59M derived: sum of 3 quarters · filed 2021-03-31 | $5.08M 10-K · filed 2021-03-31 | $5.08M 10-K · filed 2020-03-17 | ||
| 2019-09-30 | $136.00K 10-Q · filed 2020-11-09 | $136.12K 10-Q · filed 2019-11-12 | $957.20K derived: sum of 2 quarters · filed 2020-11-09 | $4.44M 10-Q · filed 2020-11-09 | $4.44M 10-Q · filed 2019-11-12 | ||
| 2019-06-30 | $821.20K 10-Q · filed 2020-08-10 | $4.31M 10-Q · filed 2020-08-10 | |||||
| 2019-03-31 | $3.48M 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |